Location History:
- Ekibin, AU (1988)
- Fig Treet Pocket, AU (1997)
- Fig Tree Pocket, AU (1990 - 2006)
Company Filing History:
2 out of 4 
2 out of 3 
1 out of 1 Years Active: 1988-2006
Title: Peter G. Bundesen: A Pioneer in Bifunctional Molecules and Diagnostic Innovations
Introduction
Peter G. Bundesen, based in Fig Tree Pocket, Australia, is a renowned inventor with a significant contribution to the field of biotechnology. With six patents to his name, his work primarily focuses on the development of innovative molecular solutions for diagnostic applications.
Latest Patents
One of Peter's latest inventions revolves around bifunctional molecules, which are chimeric antibody conjugates designed to improve diagnostic tests. This invention includes an antigen-binding region derived from a non-human antibody and a unique immunoglobulin constant region that does not occur naturally. These bifunctional molecules serve as effective positive control reagents in antibody-based diagnostic tests, complemented by associated polynucleotides that encode these innovative molecules and diagnostic assays for their use. Additionally, he has developed technology for the detection of mammalian immunodeficiency viruses, marking his contribution to advancing medical diagnostics.
Career Highlights
Throughout his career, Peter has been associated with several innovative companies, including Agen Biomedical Ltd. and Agen Limited. His experience in these organizations has allowed him to hone his skills in research and development, particularly in the realm of biotechnology and molecular diagnostics.
Collaborations
Peter has collaborated with notable professionals in the field, including Dennis B. Rylatt and Carmel J. Hillyard. These collaborations have been instrumental in pushing the boundaries of research and development, facilitating the creation of groundbreaking technologies that have implications in healthcare diagnostics.
Conclusion
Peter G. Bundesen stands out as a significant figure in biotechnology with his innovative contributions to the field of diagnostics. His work on bifunctional molecules has not only enhanced antibody-based tests but has also positioned him as a pioneer in addressing critical challenges in medical diagnostics. With his extensive patent portfolio and impactful collaborations, he continues to influence the evolution of biotechnology.